Pharmacies must be certified in the TEGSEDI REMS Program to be able to dispense TEGSEDI for adult patients with polyneuropathy of Hereditary Transthyretin-mediated Amyloidosis (hATTR).
To become authorized to dispense TEGSEDI complete the following steps:
DESIGNATE an authorized representative for the pharmacy
THE AUTHORIZED REPRESENTATIVE MUST REVIEW the REMS Program Overview
AFTER REVIEWING THE MATERIAL, COMPLETE the Pharmacy Enrollment Form and fax to the TEGSEDI REMS Program at 1-855-483-4736
Implement the necessary staff and training processes to comply with the TEGSEDI REMS Program requirements